Zhu Chen, Yiliang Bao, Yi Liu, Zhongyu Li, Dini Zhang, Meijing Xiao, Yuan Guo, Jinque Luo
{"title":"BCG-YOLO: an efficient YOLO-based framework for multi-class blood cell detection in microscopic images.","authors":"Zhu Chen, Yiliang Bao, Yi Liu, Zhongyu Li, Dini Zhang, Meijing Xiao, Yuan Guo, Jinque Luo","doi":"10.3389/fmed.2026.1934762","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Automated blood cell detection from microscopic images is essential for routine hematological examination and computer-assisted laboratory diagnosis. However, accurate detection remains challenging because of the small size, dense distribution, overlap, and indistinct boundaries of blood cells. This study aimed to develop an efficient deep learning framework for accurate multi-class detection of blood cells in microscopic images.</p><p><strong>Methods: </strong>We developed BCG-YOLO, an enhanced detector based on YOLO11n that integrates a lightweight backbone network, an improved multi-scale feature fusion module, and a dynamic detection head to improve feature representation and adaptive detection of small and densely distributed blood cells. The proposed model was evaluated on the public BCCD dataset and compared with representative one-stage detectors, transformer-based methods, and real-time object detection models. Ablation studies were conducted to assess the effectiveness of each proposed component. Additional five-fold cross-validation and paired image-level bootstrap analyses were performed for YOLO11n and BCG-YOLO.</p><p><strong>Results: </strong>On the original fixed test split, BCG-YOLO achieved an mAP@0.5 of 95.3%, an mAP@0.5:0.95 of 67.6%, and a recall of 89.8% while requiring only 3.80 GFLOPs. Under the common training and evaluation protocol used in this study, BCG-YOLO achieved the best overall detection performance among all evaluated models. Ablation experiments further demonstrated the effectiveness of the proposed modules, confirming consistent improvements in overall detection performance and computational efficiency.</p><p><strong>Conclusions: </strong>BCG-YOLO provided a favorable balance between detection accuracy and computational cost in the internal evaluation on BCCD. These findings support its feasibility for microscopic blood-cell detection, while independent external validation is required to establish generalizability across laboratories, staining protocols, and imaging systems.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1934762"},"PeriodicalIF":3.6000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677546/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2026.1934762","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Automated blood cell detection from microscopic images is essential for routine hematological examination and computer-assisted laboratory diagnosis. However, accurate detection remains challenging because of the small size, dense distribution, overlap, and indistinct boundaries of blood cells. This study aimed to develop an efficient deep learning framework for accurate multi-class detection of blood cells in microscopic images.
Methods: We developed BCG-YOLO, an enhanced detector based on YOLO11n that integrates a lightweight backbone network, an improved multi-scale feature fusion module, and a dynamic detection head to improve feature representation and adaptive detection of small and densely distributed blood cells. The proposed model was evaluated on the public BCCD dataset and compared with representative one-stage detectors, transformer-based methods, and real-time object detection models. Ablation studies were conducted to assess the effectiveness of each proposed component. Additional five-fold cross-validation and paired image-level bootstrap analyses were performed for YOLO11n and BCG-YOLO.
Results: On the original fixed test split, BCG-YOLO achieved an mAP@0.5 of 95.3%, an mAP@0.5:0.95 of 67.6%, and a recall of 89.8% while requiring only 3.80 GFLOPs. Under the common training and evaluation protocol used in this study, BCG-YOLO achieved the best overall detection performance among all evaluated models. Ablation experiments further demonstrated the effectiveness of the proposed modules, confirming consistent improvements in overall detection performance and computational efficiency.
Conclusions: BCG-YOLO provided a favorable balance between detection accuracy and computational cost in the internal evaluation on BCCD. These findings support its feasibility for microscopic blood-cell detection, while independent external validation is required to establish generalizability across laboratories, staining protocols, and imaging systems.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world